Abstract
Composites of nanofiber, nanogel, and microgels for the delivery of doxorubicin, paclitaxel, and other drugs, enhance their solubility, onsite targeted delivery, and therapeutic potency in targeted sites. Thanks to their properties. The ability of the polymer-based delivery vehicles to target specific tissues for therapeutic drug deliveries make the challenges of low binding, large size distribution and others, less significant. A scoping review assisted us to determine the coverage of the literature on biomedical application of nanofiber, nanogel, and microgels composites, by mapping the available evidence and identifying knowledge gaps. Research questions and limitations of current literature were answered.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Polymeric Materials and Polymeric Biomaterials
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
